In 2025, the sector in GCC was valued at USD 4.88 billion, representing a year-over-year increase of 3.0%.
Industry signals indicate that by 2033, the GCC Infusion Services Market is likely to reach USD 15.00 billion, delivering a CAGR of 15.1% over the forecast period.
State-funded tertiary hospital expansion and national cancer strategies are materially increasing biologic infusion capacity, particularly within centralized oncology hubs across the Gulf.
GCC health ministries’ non-communicable disease frameworks emphasize cancer control and specialty care scaling, reinforcing sustained systemic therapy infrastructure investment.
DataCube Research Report (Feb 2026): This analysis uses 2024 as the actual year, 2025 as the estimated year, and calculates CAGR for the 2025-2033 period.
*Research Methodology: This report is based on DataCube’s proprietary 3-stage forecasting model, combining primary research, secondary data triangulation, and expert validation.
[Learn more]